Viewing Study NCT06304870



Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06304870
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-15
First Post: 2024-03-04

Brief Title: Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease
Sponsor: Muhammad
Organization: Ahmadu Bello University Teaching Hospital

Study Overview

Official Title: Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease A Randomized Double-blind Controlled Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to explore Clinical Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease The main question it aims to answer is

Can Glossopharyngeal Nerve Block improve dysphagia caused by gastroesophageal reflux symptoms on the basis of rehabilitation training Participants will be randomly allocated into the control group or the experimental group all under rehabilitation treatment the experimental group will be given Glossopharyngeal Nerve Block once a day additionally The study lasts 20 days for each participant Researchers will compare the Rosenbek penetration-aspiration scale Gastroesophageal Reflux Disease Questionnaire Pressure pain threshold to see if the Glossopharyngeal Nerve Block can help improve the symptom
Detailed Description: Gastroesophageal reflux is a common digestive disorder characterized by the backflow of stomach contents and fluids into the esophagus

The goal of this clinical trial is to explore Clinical Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease The main question it aims to answer is

Can Glossopharyngeal Nerve Block improve dysphagia caused by gastroesophageal reflux symptoms on the basis of rehabilitation training Participants will be randomly allocated into the control group or the experimental group all under rehabilitation treatment the experimental group will be given Glossopharyngeal Nerve Block once a day additionally The study lasts 20 days for each participant Researchers will compare the Rosenbek penetration-aspiration scale Gastroesophageal Reflux Disease Questionnaire Pressure pain threshold to see if the Glossopharyngeal Nerve Block can help improve the symptom

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None